Renaissance Technologies - EVAXION BIOTECH A S ownership

EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 8 filers reported holding EVAXION BIOTECH A S in Q3 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EVAXION BIOTECH A S
ValueSharesWeighting
Q2 2022$22,000
-75.6%
11,600
-42.8%
0.00%
Q4 2021$90,00020,2700.00%
Other shareholders
EVAXION BIOTECH A S shareholders Q3 2022
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 18,071$32,5280.14%
Telemetry Investments, L.L.C. 37,500$680.11%
Beacon Capital Management, LLC 6,881$12,2140.00%
PURA VIDA INVESTMENTS, LLC 16,842$29,8950.00%
MORGAN STANLEY 3,696$6,5600.00%
Citadel Advisors 13,000$23,4000.00%
Citadel Advisors 500$9000.00%
Citadel Advisors 1,485$2,6730.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 41,600$74,8800.00%
UBS Group AG 5,081$9,0440.00%
View complete list of EVAXION BIOTECH A S shareholders